Literature DB >> 21887589

Photothermal cancer therapy and imaging based on gold nanorods.

Won Il Choi1, Abhishek Sahu, Young Ha Kim, Giyoong Tae.   

Abstract

Gold nanorods (GNRs), which strongly absorb near-infrared (NIR) light, have shown great potential in fields of biomedical application. These include photothermal therapy, molecular imaging, biosensing, and gene delivery, especially for the treatment of diseased tissues such as cancer. These biomedical applications of GNRs arise from their various useful properties; photothermal (nanoheater) properties, efficient large scale synthesis, easy functionalization, and colloidal stability. In addition, GNRs do not decompose and have an enhanced scattering signal and tunable longitudinal plasmon absorption which allow them to be used as a stable contrast agent. Therefore, GNRs are also promising theranostic agents, combining both tumor diagnosis and treatment. In this review, we discuss the recent progress of in vitro and in vivo explorations of the diagnostic and therapeutic applications of GNRs as a component of cancer therapy.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21887589     DOI: 10.1007/s10439-011-0388-0

Source DB:  PubMed          Journal:  Ann Biomed Eng        ISSN: 0090-6964            Impact factor:   3.934


  24 in total

1.  Gold Nanorod-assisted Optical Stimulation of Neuronal Cells.

Authors:  Chiara Paviolo; Sally L McArthur; Paul R Stoddart
Journal:  J Vis Exp       Date:  2015-04-27       Impact factor: 1.355

2.  Polydopamine-enabled surface functionalization of gold nanorods for cancer cell-targeted imaging and photothermal therapy.

Authors:  Kvar C L Black; Ji Yi; José G Rivera; Daria C Zelasko-Leon; Phillip B Messersmith
Journal:  Nanomedicine (Lond)       Date:  2012-08-14       Impact factor: 5.307

3.  Gold nanorod biochip functionalization by antibody thiolation.

Authors:  Xuefeng Wang; Zhong Mei; Yanyan Wang; Liang Tang
Journal:  Talanta       Date:  2014-11-20       Impact factor: 6.057

4.  Anchoring Effects of Surface Chemistry on Gold Nanorods: Modulates Autophagy.

Authors:  Feng Li; Xing-Jie Liang; Shengliang Li; Chunqiu Zhang; Weipeng Cao; Benyu Ma; Xiaowei Ma; Shubin Jin; Jinchao Zhang; Paul C Wang
Journal:  J Mater Chem B       Date:  2015-03-13       Impact factor: 6.331

Review 5.  Multifunctional gold nanoparticles for diagnosis and therapy of disease.

Authors:  Aneta J Mieszawska; Willem J M Mulder; Zahi A Fayad; David P Cormode
Journal:  Mol Pharm       Date:  2013-02-11       Impact factor: 4.939

Review 6.  Physical energy for drug delivery; poration, concentration and activation.

Authors:  Shanmugamurthy Lakshmanan; Gaurav K Gupta; Pinar Avci; Rakkiyappan Chandran; Magesh Sadasivam; Ana Elisa Serafim Jorge; Michael R Hamblin
Journal:  Adv Drug Deliv Rev       Date:  2013-06-07       Impact factor: 15.470

7.  Actively Targeted Deep Tissue Imaging and Photothermal-Chemo Therapy of Breast Cancer by Antibody-Functionalized Drug-Loaded X-Ray-Responsive Bismuth Sulfide@Mesoporous Silica Core-Shell Nanoparticles.

Authors:  Lihua Li; Yao Lu; Chunyan Jiang; Ye Zhu; Xianfeng Yang; Xiaoming Hu; Zefeng Lin; Yu Zhang; Mingying Peng; Hong Xia; Chuanbin Mao
Journal:  Adv Funct Mater       Date:  2017-12-11       Impact factor: 18.808

8.  Upconverting organic dye doped core-shell nano-composites for dual-modality NIR imaging and photo-thermal therapy.

Authors:  Guobin Shan; Ralph Weissleder; Scott A Hilderbrand
Journal:  Theranostics       Date:  2013-03-21       Impact factor: 11.556

Review 9.  Gold nanorods based platforms for light-mediated theranostics.

Authors:  Zhenjiang Zhang; Jing Wang; Chunying Chen
Journal:  Theranostics       Date:  2013-03-01       Impact factor: 11.556

10.  Tissue distribution and efficacy of gold nanorods coupled with laser induced photoplasmonic therapy in ehrlich carcinoma solid tumor model.

Authors:  Mostafa A El-Sayed; Ali A Shabaka; Osama A El-Shabrawy; Nemat A Yassin; Sawsan S Mahmoud; Siham M El-Shenawy; Emad Al-Ashqar; Wael H Eisa; Niveen M Farag; Marwa A El-Shaer; Nabila Salah; Ahmed M Al-Abd
Journal:  PLoS One       Date:  2013-10-02       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.